In perimenopausal or menopausal women, patients with central precocious puberty, polycystic ovary syndrome, or a long-term GnRHa treatment, the high risk of obesity is correlated with high GnRH levels. This evidence concerns the gene GNRH1 and obesity due to melanocortin 4 receptor deficiency.